Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Johnson and Johnson
Harvard Business School
Moodys
Medtronic

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019516

See Plans and Pricing

« Back to Dashboard

NDA 019516 describes MS CONTIN, which is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. Additional details are available on the MS CONTIN profile page.

The generic ingredient in MS CONTIN is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 019516
Tradename:MS CONTIN
Applicant:Purdue Pharma Lp
Ingredient:morphine sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019516
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 019516
Suppliers and Packaging for NDA: 019516
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516 NDA Rhodes Pharmaceuticals L.P. 42858-515 42858-515-01 100 TABLET in 1 BOTTLE, PLASTIC (42858-515-01)
MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516 NDA Rhodes Pharmaceuticals L.P. 42858-631 42858-631-01 100 TABLET in 1 BOTTLE, PLASTIC (42858-631-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength30MG
Approval Date:May 29, 1987TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength60MG
Approval Date:Apr 8, 1988TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength15MG
Approval Date:Sep 12, 1989TE:ABRLD:Yes

Expired US Patents for NDA 019516

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-003 Sep 12, 1989   Start Trial   Start Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-004 Jan 16, 1990   Start Trial   Start Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-005 Nov 8, 1993   Start Trial   Start Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-002 Apr 8, 1988   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Mallinckrodt
Dow
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.